- FDA approves major depressive drug after rejecting it multiple times in past two decades Endpoints News
- FDA approves Exxua for depression treatment after multiple rejections over more than two decades The Hill
- FDA Approves Gepirone Extended-Release for Treatment of Major Depressive Disorder Pharmacy Times
- Fabre-Kramer Pharmaceuticals Announces FDA Approval of EXXUA™, the First and Only Oral Selective 5HT1a Receptor Agonist for the Treatment of Major Depressive Disorder in Adults PR Newswire
- Decades-long regulatory odyssey ends with FDA nod for Fabre-Kramer’s depression med Exxua FiercePharma
- View Full Coverage on Google News
Read More: FDA approves major depressive drug after rejecting it multiple times in past two